Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population

[1]  Steven J. M. Jones,et al.  Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma , 2017, Cell.

[2]  Edwin Wang,et al.  Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome , 2017, Genom. Proteom. Bioinform..

[3]  N. Trehanpati,et al.  Immune Regulation by T Regulatory Cells in Hepatitis B Virus‐Related Inflammation and Cancer , 2017, Scandinavian journal of immunology.

[4]  Y. Liu,et al.  Genomic Variant in IL-37 Confers A Significant Risk of Coronary Artery Disease , 2017, Scientific Reports.

[5]  Q. Ning,et al.  Virus-induced hepatocellular carcinoma with special emphasis on HBV , 2017, Hepatology International.

[6]  Hao Chen,et al.  IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation , 2017, PloS one.

[7]  A. Nasr,et al.  Association of IL‐37 gene polymorphisms with susceptibility to tuberculosis in Saudi subjects , 2016, Microbiology and immunology.

[8]  J. Niu,et al.  Association of IL-10 polymorphisms with hepatitis B virus infection and outcome in Han population , 2016, European Journal of Medical Research.

[9]  C. Dinarello,et al.  Suppression of innate inflammation and immunity by interleukin‐37 , 2016, European journal of immunology.

[10]  K. Matsuura,et al.  Host genetic variants influencing the clinical course of Hepatitis B virus infection , 2016, Journal of medical virology.

[11]  L. Tian,et al.  Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections , 2016, Clinical Reviews in Allergy & Immunology.

[12]  Q. Qin,et al.  Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease. , 2015, Journal of molecular endocrinology.

[13]  Yong-ming Yao,et al.  Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells , 2015, Scientific Reports.

[14]  M. Zhang,et al.  Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation , 2015, PloS one.

[15]  O. Yokosuka,et al.  HBV Core Protein Enhances Cytokine Production , 2015, Diseases.

[16]  Zhenghong Yuan,et al.  New insights into hepatitis B virus biology and implications for novel antiviral strategies , 2015 .

[17]  Shan Li,et al.  Association Between IL-4 Polymorphisms and Risk of Liver Disease , 2015, Medicine.

[18]  Su‐Hyung Park,et al.  Immune-mediated Liver Injury in Hepatitis B Virus Infection , 2015, Immune network.

[19]  T. Asselah,et al.  Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  E. Sagnelli,et al.  Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease , 2015, Journal of medical virology.

[21]  C. Seeger,et al.  Molecular biology of hepatitis B virus infection. , 2015, Virology.

[22]  G. Lou,et al.  The Sterile Inflammation in the Exacerbation of HBV-Associated Liver Injury , 2015, Mediators of inflammation.

[23]  B. Palmer,et al.  Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8 , 2015, Proceedings of the National Academy of Sciences.

[24]  C. Dinarello,et al.  Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells , 2014, Proceedings of the National Academy of Sciences.

[25]  A. Bertoletti,et al.  Age-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation , 2014, Front. Immunol..

[26]  E. Gupta,et al.  Reverse vertical transmission of hepatitis-B from transfusion-infected children to biological mothers , 2014, Indian Pediatrics.

[27]  E. Wang,et al.  Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. , 2014, Seminars in cancer biology.

[28]  Pei-Jer Chen,et al.  Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model , 2014, PloS one.

[29]  K. Pan,et al.  Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells , 2014, Scientific Reports.

[30]  A. Schuch,et al.  The Role of Natural Killer Cells and CD8+ T Cells in Hepatitis B Virus Infection , 2014, Front. Immunol..

[31]  Dongsheng Hu,et al.  IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity , 2014, Journal of Translational Medicine.

[32]  Yanfang Jiang,et al.  Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. , 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[33]  Nisha A. Viswan,et al.  Single nucleotide polymorphisms in CXCR1 gene and its association with hepatitis B infected patients in Saudi Arabia. , 2013, Annals of hepatology.

[34]  F. Sanai,et al.  Epidemiology of Viral Hepatitis in Saudi Arabia: Are We Off the Hook? , 2012, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[35]  L. Serino,et al.  Hepatitis A: Epidemiology and prevention in developing countries. , 2012, World journal of hepatology.

[36]  Joan M. Block,et al.  Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options , 2010, Hepatology.

[37]  B. Palmer,et al.  Interleukin 37 is a fundamental inhibitor of innate immunity , 2010, Nature Immunology.

[38]  Ding‐Shinn Chen,et al.  Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model , 2010, Proceedings of the National Academy of Sciences.

[39]  B. McMahon.  The natural history of chronic hepatitis B virus infection , 2009, Hepatology.

[40]  S. Litwin,et al.  The Amount of Hepatocyte Turnover That Occurred during Resolution of Transient Hepadnavirus Infections Was Lower When Virus Replication Was Inhibited with Entecavir , 2008, Journal of Virology.

[41]  Zheng Zeng,et al.  A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population , 2008, BMC infectious diseases.

[42]  Jack A. Taylor,et al.  TAGster: efficient selection of LD tag SNPs in single or multiple populations , 2007, Bioinform..

[43]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans , 2007 .

[44]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[45]  J. Sung,et al.  Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection , 2002, American Journal of Gastroenterology.

[46]  J. Sung,et al.  Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. , 2002 .

[47]  S. Pauluzzi,et al.  Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients , 1995, European Journal of Epidemiology.

[48]  L. Hwang,et al.  PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINE , 1983, The Lancet.

[49]  R. Newcombe,et al.  MATERNAL DEATHS , 1975, The Lancet.

[50]  Jinfeng Zou,et al.  Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer. , 2016, JAMA oncology.

[51]  Shan Li,et al.  Association Between IL-4 Polymorphisms and Risk of Liver Disease An Updated Meta-Analysis , 2015 .

[52]  L. Serino,et al.  Hepatitis B: Epidemiology and prevention in developing countries. , 2012, World journal of hepatology.

[53]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. , 2007, Hepatology.

[54]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.